Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:02546066n
Noun Concept
EL
No term available
EN
Ponatinib, sold under the brand name Iclusig, is a medication developed by ARIAD Pharmaceuticals for the treatment of chronic myeloid leukemia and Philadelphia chromosome–positive acute lymphoblastic leukemia. Wikipedia
Relations
Sources
IS A
ακόρεστη ένωση
MEDICAL CONDITION TREATED
οξεία μυελογενής λευχαιμία
Γαστροεντερικός στρωματικός όγκος
PHYSICALLY INTERACTS WITH
ret proto-oncogene
EN
ABL
SUBJECT HAS ROLE
αναστολέας της τυροσινικής κινάσης
αναστολέας της πρωτεϊνικής κινάσης
EN
antineoplastic
USE
φάρμακο

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License